Dual-Hormone Artificial Pancreas Improves Glucose Control in Diabetes
A Canadian study has concluded a novel dual-hormone artificial pancreas system improves glucose control in patients with type 1 diabetes. Researchers from McGill University’s Faculty of Medicine compared the dual-hormone system with a rapid insulin-alone artificial pancreas. According to the findings the D-HAP increased the blood glucose time in range from 74% to 84%. The…